Marksans Pharma Limited (MARKSANS)
₹294.7
INR+4.50(+1.55%)
As of December 27, 2024 9:59:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹13816.97 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹13171.47 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
39.80
Forward P/E
Price to Earnings ratio based on forecasted earnings
27.20
PEG Ratio
Price/Earnings to Growth ratio
5.00
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
6.09
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
59.75%
Operating Margin
Operating income as a percentage of revenue
18.29%
Return on Equity
Net income as a percentage of shareholders' equity
15.04%
Revenue (TTM)
Total revenue over trailing 12 months
₹2267.99 Cr+18.099999999999998%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹554.12 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹7.66+29.299999999999997%
Balance Sheet
Total Cash
Total cash and short-term investments
₹700.57 Cr
Total Debt
Total short-term and long-term debt
₹244.06 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
11.70%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹130 - ₹358.7
Beta
Measure of stock's volatility compared to the market
1.67
Shares Outstanding
Total number of shares issued by the company
₹45.32 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.81%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
NA